NVNO 241018 2.50C (NVNO241018C2500) Stock Options, News & Quotes

0.50
-0.35-41.18%

15min DelayClose Oct 2 15:56 ET

0.50High0.50Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Sep 29 14:24

May be time to start a swing! NFA

$enVVeno Medical (NVNO.US)$ Saying this for a few reasons! But the big drop from the offering makes a nice bottom! And Y’all knows i likes me some bottoms! Hehehe. Crash from offering gave a 52wk low! But they also only had 1 last module to complete before submitting to FDA for PMA! That was / is to be complete Q4! So that brings me to my speculative part of my interest! Hehehe. Is it very possible that they did the offering now so they have the money going forwar...

Jaguar8

Sep 26 21:27

NEWS

$enVVeno Medical (NVNO.US)$
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public OfferingenVVeno Medical (NASDAQ:NVNO) has announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock (or pre-funded warrants) at $3.50 per share. The company expects to receive gross proceeds of approximately $15.0 millionfrom the offering, excluding underwriting discounts and other expenses. The offering is expected to close around September 30, 2024.
The co...

Jaguar8

Aug 14 12:03

NEWS

$enVVeno Medical (NVNO.US)$
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
enVVeno Medical has made significant progress in its FDA premarket approval (PMA) application for the VenoValve, a surgical replacement venous valve. The company has successfully submitted, and the FDA has approved, four out of five modules required for the PMA application. The fifth and final module, containing clinical data from the SAVVE U.S. pivotal trial, is expecte...

Jaguar8

Jun 17 11:44

NEWS

$enVVeno Medical (NVNO.US)$
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical announced the presentation of new interim venous ulcer healing data from the VenoValve U.S. pivotal trial at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024. The data, presented by Dr. Cassius Iyad Ochoa Chaar of Yale School of Medici...

HALFtraderHALFamazin

Dec 8, 2021 08:35

This will be $50+ by end of 2022

$enVVeno Medical (NVNO.US)$